- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 28-08-2026: General Updates
28-08-2026 | 03:36 pm
28-08-2026 | 03:36 pm
Aurobindo Pharma's subsidiary, Apitoria Pharma, concluded its US FDA inspection at Unit-VI, an API manufacturing facility. It resulted in three procedural observations, to which the company will respond promptly.
No comments yet. Be the first to comment!